GeneDx Holdings WGS Unrealized gains (losses) on available-for-sale securities
Unrealized gains (losses) on available-for-sale securities at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's unrealized gains (losses) on available-for-sale securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's unrealized gains (losses) on available-for-sale securities?
- GeneDx Holdings (WGS) reported unrealized gains (losses) on available-for-sale securities of -$253K in Q1 2026.
- How has GeneDx Holdings's unrealized gains (losses) on available-for-sale securities changed year-over-year?
- GeneDx Holdings's unrealized gains (losses) on available-for-sale securities decreased by 437.3% year-over-year, from $75K to -$253K.
- What does unrealized gains (losses) on available-for-sale securities mean?
- This metric captures the unrealized gains or losses resulting from changes in the fair value of investment securities classified as available-for-sale. Unlike realized gains, these amounts are recorded in equity rather than net income until the securities are sold or impaired. It provides insight into the market-driven performance of the company's investment portfolio and its potential impact on total shareholder equity.